Given that chronic pancreatitis is a risk factor for PDAC and that an inflammatory environment can directly promote tumor initiation [42,59], we employed here TD protocols P2 and a third protocol (P3, based on a combination of IGF-1, SCF and transferrin) for the generation of insulin-expressing cells. Here, KITLG is linked to chronic pancreatitis.